🏛️ Verified NIH Record • Updated 2026-04-13

Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2 (NCT03048279)

🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: M.D. Anderson Cancer Center

🩺 Plain-English Summary (8th-Grade Level)

Objectives: To contribute new and prospective data to our existing database library for patients with MEN1 and MEN2 at The University of Texas M.D. Anderson Cancer Center.

Who can join: Review the eligibility criteria below.

Location: University of Texas MD Anderson Cancer Center — Houston, Texas

🧪 Interventions in This Study

  • Questionnaires (BEHAVIORAL)

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

  • University of Texas MD Anderson Cancer Center — Houston, Texas

📞 Contact the Study Coordinator

Phone: (877) 632-6789

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Multiple Endocrine Neoplasia Syndromes clinical trials

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗